1036 A 24-WEEK, PARALLEL-GROUP, OPEN-LABEL, RANDOMIZED CLINICAL TRIAL COMPARING THE EARLY ANTIVIRAL EFFICACY OF TELBIVUDINE AND ENTECAVIR IN THE TREATMENT OF HBEAG-POSITIVE CHRONIC HEPATITIS B

✍ Scribed by Zheng, M.-H.; Shi, K.-Q.; Dai, Z.-J.; Ye, C.; Chen, Y.-P.

• Book ID: 123491707
• Publisher: Elsevier Science
• Year: 2010
• Tongue: English
• Weight: 50 KB
• Volume: 52
• Category: Article
• ISSN: 0168-8278
• DOI: 10.1016/S0168-8278(10)61037-9